For Telehealth Platforms

Pharmacy partner selection. At the scale you actually run.

Telehealth peptide platforms face procurement realities most clinical practices never see. 5,000 patient prescriptions per month means partner pharmacy quality compounds across thousands of patient outcomes. The publication that treats your scale as the actual variable.

50
States to track
503A+B
Both pharmacy types
Multi-Rx
Network depth

If you run procurement for a telehealth peptide platform, you are not selecting a single pharmacy partner. You are selecting a pharmacy network. Multi-state license coverage, capacity at scale, regulatory exposure across jurisdictions, and consistency of patient experience all matter at orders of magnitude beyond what a single-clinic operation deals with. This is editorial coverage built for that scale.

§ 01

What you actually need to know

Four procurement realities specific to telehealth platforms that smaller practices do not need to think about, but you cannot avoid.

Multi-state pharmacy networks

A 503A pharmacy in one state may not be able to ship to your patient in another. Network coverage analysis, license verification at scale, and contingency planning when a partner pharmacy loses a state.

Capacity validation

Your pharmacy partner can handle 200 prescriptions per month and tells you they can scale. Can they actually? Capacity validation procedures before you commit volume.

Regulatory exposure mapping

The geographic footprint of your patient base creates regulatory exposure across state pharmacy boards, FDA jurisdictions, and DEA scheduling realities. How to map and manage that exposure.

Compounding agreement structure

Anchor pharmacy with backup, multi-pharmacy network, hybrid 503A and 503B model. Each has trade-offs at the scale you operate.

§ 02

How we cover this

Coverage areas specific to telehealth operations and procurement.

Pharmacy partner diligence at scale

Vetting frameworks built for telehealth multi-pharmacy networks, not single-clinic relationships.

Regulatory tracking

Updates that affect your patient base across all 50 states, not just your home state.

Compounding agreement analysis

Structure patterns from telehealth platforms operating at $20M+ ARR. Real frameworks, not legal generics.

Sourcing intelligence

Pricing leverage at telehealth volume. Competitive benchmarks. Pharmacy partner negotiation frameworks.

Related Coverage

Where to read next

Regulatory

FDA Category 1 vs 2: where 14 peptides stand now

Read →
Tracker

FDA peptide regulatory tracker

Read →
Guides

All sourcing guides

Read →
Free · Quarterly Edition

The US Peptide Sourcing Buyer’s Guide

A 30-page procurement reference for the four segments. Regulatory landscape, supplier vetting frameworks, COA interpretation, pricing benchmarks, red flags. Free download.

Get the Buyer’s Guide →